Macquarie Group LTD Procept Bio Robotics Corp Transaction History
Macquarie Group LTD
- $90.3 Billion
- Q3 2024
A detailed history of Macquarie Group LTD transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Macquarie Group LTD holds 208,869 shares of PRCT stock, worth $13.8 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
208,869Holding current value
$13.8 Million% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
284Shares Held
40MCall Options Held
262KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA5.14MShares$339 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$230 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$116 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA1.49MShares$98.4 Million0.02% of portfolio
-
Loomis Sayles & CO L P1.21MShares$79.7 Million0.12% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.94B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...